Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
September 21, 2009: Republic of Macedonia The Republic of Macedonia officially enters the recession after experiencing a drop in GDP of 0.9% in the first quarter, followed by 1.4% in the second quarter.
=== Epstein-Barr virus === The Epstein-Barr virus (EBV) infects about 90 to 95% of adults and can cause infectious mononucleosis. A study of more than 10 million US military members compared 801 people who developed MS to 1,566 matched controls who did not. The study found a 32-fold increased risk of MS development following EBV infection. It did not find an increased risk after infection with other viruses, including the similar cytomegalovirus. These findings strongly suggest that EBV is necessary for MS onset, although EBV alone may be insufficient to cause it. The nuclear antigen of EBV, which is the most consistent marker of EBV infection across all strains, has been identified as a direct source of autoreactivity in the human body. These antigens appear more likely to promote autoimmunity in vitamin D deficient persons. The EBV protein EBNA1 shares similarities with three human proteins, including the brain protein GlialCAM. Because of molecular mimicry, the immune system in MS mistakenly may attack these proteins. Two are part of the nervous system, while the third is a "guardian molecule" which protects the body against autoimmunity.
=== DESI imaging === Desorption electrospray Ionization is a less destructive technique, which couples simplicity and rapid analysis of the sample. The sample is sprayed with an electrically charged solvent mist at an angle that causes the ionization and desorption of various molecular species. Then, two-dimensional maps of the abundance of the selected ions in the surface of the sample in relation with the spatial distribution are generated. This technique is applicable to solid, liquid, frozen and gaseous samples. Moreover, DESI allows analyzing a wide range of organic and biological compounds, as animal and plant tissues and cell culture samples, without complex sample preparation Although, this technique has the poorest resolution among other, it can create high-quality image from a large area scan, as a whole body section scanning. Nano-DESI imaging Nanospray Desoprtion Electrospray Ionization is a minimally destructive soft ionization technique based on liquid extraction. The basic setup consists of two fused silica capillaries (primary and secondary). An extraction solvent is supplied through a primary capillary, forming a liquid bridge at the interface of the two capillaries and extracting molecules from the tissue surface. Afterwards, the extracted analytes are transferred and nebulized through the secondary capillary inside the inlet of a mass spectrometer. Nano-DESI offers great solvent versatility and the possibility of analyte quantification by introducing of internal standards directly into the solvent.
In tropical and most temperate regions, surplus foods were typically preserved using curing (often by salting) and drying, while means of cold food storage were generally unavailable unless in arctic, subarctic or alpine regions where humans can conveniently harvest natural ice (from glaciers or frozen waterbodies) and/or made use of natural coolness in caves, root cellars and winter weather. In the 19th century, the rise of ice trade enabled the development of cold chains. In the late 19th through mid-20th centuries, mechanical refrigeration was invented, improved and greatly expanded in its reach, and refrigeration has thus rapidly evolved in the forms of temperature-controlled rail cars, refrigerator trucks and the ubiquitous white goods refrigerators and freezers in both stores and average homes in most countries. The introduction of refrigerated rail cars also contributed to the settlement of areas that were not on earlier main transport channels such as rivers, harbors, or valley trails, and sparked the building of large cities which are able to thrive in areas that were otherwise thought to be inhospitable due to hot climate, such as Houston, Texas, and Las Vegas, Nevada. In most developed countries today, cities and towns are heavily dependent upon refrigeration in the food processing, distribution and retail industries (such as supermarkets and butcher shops) to maintain food safety for daily consumption.
Sources: en.wikipedia.org
Buildings, operations, and management have become increasingly sophisticated since the mid-20th century, when international airports began to provide infrastructure for international civilian flights. Detailed technical standards have been developed to ensure safety, and common coding systems have been implemented to provide global consistency. The physical structures that serve millions of individual passengers and flights are among the most complex and interconnected in the world. By the second decade of the 21st century, there were over 1,200 international airports and almost two billion international passengers, along with 50 million metric tons (49,000,000 long tons; 55,000,000 short tons) of cargo passing through them annually. Border inspections are also meant to protect each country's agriculture from pests. National and international phytosanitary authorities maintain databases of border interceptions, occurrences, and establishments. Bebber et al., 2019 analyzes such records and finds that they underreport many important pest species, that island nations are more vulnerable because they have lower border-to-area ratios, and that pests are moving poleward to follow humans' crops as our crops follow global warming. A 'Quilantan' or 'Wave Through' entry is a phenomenon at American border checkpoints authorising a form of non-standard but legal entry without any inspection of travel documents. It occurs when border security personnel at a border crossing admit some individuals without conducting a standard interview or document review.
oxidative phosphorylation Also electron transport-linked phosphorylation or terminal oxidation. The process by which cells use chemical energy obtained by the oxidation of nutrients to power the production of adenosine triphosphate (ATP). Oxidative phosphorylation couples two related processes: in the electron transport chain, a series of enzyme-catalyzed redox reactions transfers electrons from energetic donors such as NADH and FADH through various intermediates and ultimately to a terminal electron acceptor such as molecular oxygen (O2); the energy liberated by these reactions is simultaneously used in chemiosmosis to move protons (H+) across a membrane and against their concentration gradient, generating an electrochemical potential which powers ATP synthase, an enzyme that catalyzes the phosphorylation of ADP into ATP. In eukaryotes, both of these processes are carried out by proteins embedded in the membranes of mitochondria and chloroplasts; in prokaryotes, they occur in the cell membrane.
==== Children's books and other short works ==== In addition to his mythopoeic compositions, Tolkien enjoyed inventing fantasy stories to entertain his children. He wrote annual Christmas letters from Father Christmas for them, building up a series of short stories (later compiled and published as The Father Christmas Letters). Other works included Mr. Bliss and Roverandom (for children), and Leaf by Niggle (part of Tree and Leaf), The Adventures of Tom Bombadil, Smith of Wootton Major and Farmer Giles of Ham. Roverandom and Smith of Wootton Major, like The Hobbit, borrowed ideas from his legendarium.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.